Our research focuses on the five core coverage areas below. We apply our rigorous research methodology to our reports, charts, forecasts, and more to keep our clients at the forefront of key developments and trends before they hit the mainstream.
Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
The healthcare and pharma industry has been slower to embrace digital marketing compared with other US verticals we track. Heavy regulation makes ad targeting more difficult, which has kept traditional media buys and in-person marketing popular. However, the coronavirus pandemic restricted many of these in-person touchpoints, which caused both the B2B and business-to-consumer (B2C) aspects of the healthcare and pharma industry to further embrace digital advertising.
We expect the US healthcare and pharma industry will spend $9.53 billion on digital advertising this year, up 14.2% from 2019.
With a public health crisis serving as the single biggest factor impacting advertising this year, it shouldn’t come as a surprise that healthcare and pharma will be among the fastest-growing industries in digital ad spending, coming second only to the computing products and consumer electronics vertical (whose spend will grow by 18.0% in 2020).
While healthcare and pharma digital ad spend has grown faster in previous years, its 2020 growth is substantial, as the total US digital ad market is expected to grow by only 1.7%.
To learn more about how the pandemic is accelerating healthcare and pharma digital ad spending, eMarketer PRO subscribers can read our recent report: